About us
History
Leaderships
Team
EU grants
Requests for Proposal
Sustainability – ESG
Bussines strategy
Quality policy
Virtual Tour
Services
Drug Substance Manufacturing
Fill & Finish
Gene to Vial: End-to-End Development
Process Development
Analytics
Cell Line Development & Banking
Science Hub
Science News
Resources
News & Events
Press releases
Events
Content to download
Investors
Corporate documents
Shareholders and shares
Periodic reports
Current reports
Sustainability reports
Corporate governance at Mabion
Financial data
For Investors
Calendar
Contact us
Contact form
Contact for investors
Contact for media
Careers
EN
Science News
Resources
Manufacturing
CHO Cell Lines for Recombinant Protein Production
Drug development
,
Drug product
,
Manufacturing
Leading European CDMO for Drug Product Manufacturing
Drug development
,
Drug product
,
Manufacturing
Antibodies Development Best Practices for CDMO Collaboration
Drug development
,
Manufacturing
,
Monoclonal antibody
Biologics CDMO Solutions for the Future of Therapeutics
Biologics
,
Drug development
,
Manufacturing
Bioprocess Operation Modes and Advanced Bioreactor Technology
Cell culture
,
Drug substance
,
Manufacturing
Ion Exchange Chromatography in Monoclonal Antibodies Purification
Analytics
,
Manufacturing
Metabolite and nutrient analysis as crucial components for optimal CHO cell culture upstream process
Cell culture
,
Drug substance
,
Manufacturing
Mycoplasma contamination in biopharmaceutical manufacturing
Biologics
,
Cell culture
,
Contamination
,
Manufacturing
Impact of glycosylation on the effector functions of monoclonal antibodies: a case study of rituximab
Bioanalytics
,
Biologics
,
Drug substance
,
Manufacturing
Previous
1
2
3